Article
NaoXinTong Inhibits the Advanced Atherosclerosis and Enhances the Plaque Stability in Apolipoprotein E Deficient Mice.
Journal of cardiovascular pharmacology - 1 Mar 2016
Yang Xiaoxiao, Sun Lei, Li Yan, Ma Chuanrui, Yang Jie, Zhang Wenwen, Zhao Buchang, Jia Lifu, Duan Yajun, Han Jihong, Li Xiaoju, Chen Yuanli
Abstract excerpt
Buchang NaoXinTong (NXT), a Chinese medicine, has been widely used to treat patients with coronary heart disease in China. However, the underlying mechanisms need more elucidations. In this study, we investigated if NXT can inhibit the progression of the established lesions while stabilizing plaques. Apolipoprotein E deficient (apoE(-/-)) mice in 3 groups received following treatment: group 1 was fed a high-fat...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
